Cargando…
SUN-LB055 Targeting Mutant p53 Alone or in Combination with a Phosphatidylserine Specific Antibody Suppresses Growth and Metastasis of Human Breast Cancer: A Strategy Towards Enhancing Personalized Medicine
Mutations in the tumor suppressor p53 gene are frequently associated with various cancers, including human breast cancer. Unlike wild-type p53 (wtp53), mutant p53 protein (mtp53) fails to promote apoptosis, resulting in tumor cell survival and resistance to chemotherapeutic drugs. Consequently, rest...
Autores principales: | Liang, Yayun, Besch-Williford, Cynthia, Belenchia, Anthony, Brekken, Rolf, Hyder, Salman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553059/ http://dx.doi.org/10.1210/js.2019-SUN-LB055 |
Ejemplares similares
-
Inhibiting Growth of Human Triple-Negative Breast Cancer Cells by Activating Mutant p53 Protein Alone or in Combination With a Phosphatidylserine-Targeting Antibody
por: Liang, Yayun, et al.
Publicado: (2021) -
APR-246 alone and in combination with a phosphatidylserine-targeting antibody inhibits lung metastasis of human triple-negative breast cancer cells in nude mice
por: Liang, Yayun, et al.
Publicado: (2019) -
A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts
por: Liang, Yayun, et al.
Publicado: (2018) -
SAT-LB055 Using Fluidics to Model the Genomic Evolution of Metastatic Breast Cancer
por: Byrne, Charles, et al.
Publicado: (2019) -
Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells
por: Cook, Matthew T, et al.
Publicado: (2016)